Tien Dam

Company: Biogen

Job title: Executive Director & Head of Medical, Neurodegeneration Development Unit, Movement Disorders

Seminars:

BIIB122: a LRRK2 Small Molecule Inhibitor for Parkinson’s Disease 8:45 am

LRRK2 as a target against Parkinson’s Disease Reviewing phase I data safety and target engagement Evaluating study design approaches for ongoing clinical trialsRead more

day: Day Two